Bolt Biotherapeutics (BOLT) Stock: Buy, Sell, or Hold?
BOLT - Bolt Biotherapeutics, Inc. Common Stock
$4.19
0.05 (1.21%)
▲
5d:
-1.18%
30d:
+14.79%
90d:
+9.4%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 11, 2026
18d
Get Alerted When BOLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BOLT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BOLT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BOLT is currently trading at $4.19, which is considered extended relative to its 30-day fair value range of $3.50 to $4.09.
Technical Outlook: Technically, BOLT is in a downtrend. Immediate support is located at $3.76, while resistance sits at $4.68.
Market Sentiment: BOLT scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $29.00 (+592.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BOLT is in a downtrend. Immediate support is located at $3.76, while resistance sits at $4.68.
Market Sentiment: BOLT scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $29.00 (+592.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.50 -
$4.09
Company Quality Score
25/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (3/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 592.1% below Wall St target ($29.00)
- WARNING: Composite score 25/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.50 -
$4.09
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.76
Resistance Level
$4.68
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.21
Wall Street Target
$29.00
(+592.1%)
Revenue Growth (YoY)
-99.7%
Share & Embed Analysis
Last updated: October 23, 2026 7:49 AM ET
Data refreshes hourly during market hours. Next update: 8:49 AM
Data refreshes hourly during market hours. Next update: 8:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BOLT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 62 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 44 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 61 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 66 BUY |
